Cargando…
Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy
OBJECTIVE: To assess the potential acute effects regarding the immunogenicity and safety of non-adjuvanted influenza A H1N1/2009 vaccine in patients with mixed connective tissue disease and healthy controls. METHODS: Sixty-nine mixed connective tissue disease patients that were confirmed by Kasukawa...
Autores principales: | Miossi, Renata, Fuller, Ricardo, Moraes, Júlio C. B., Ribeiro, Ana Cristina M., Saad, Carla G. S., Aikawa, Nadia E., Miraglia, João L, Ishida, Maria A, Bonfá, Eloisa, Caleiro, M Teresa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584286/ https://www.ncbi.nlm.nih.gov/pubmed/23525305 http://dx.doi.org/10.6061/clinics/2013(02)OA02 |
Ejemplares similares
-
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases
por: Tonacio, Adriana Coracini, et al.
Publicado: (2021) -
Autoimmune response following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis
por: Aikawa, Nadia E, et al.
Publicado: (2011) -
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Gualano, Bruno, et al.
Publicado: (2022) -
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
por: Silva, Clovis A., et al.
Publicado: (2022) -
Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
por: Aikawa, Nadia Emi, et al.
Publicado: (2011)